CA
CVS icon

Continuum Advisory’s CVS Health CVS Stock Holding History

Continuum Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.8M Buy
80,736
+1,763
+2% +$136K 0.56% 40
2025
Q4 		$6.27M Buy
78,973
+2,825
+4% +$223K 0.63% 39
2025
Q3 		$5.74M Buy
76,148
+7,639
+11% +$524K 0.61% 37
2025
Q2 		$4.73M Buy
68,509
+68,422
+78,646% +$4.49M 0.57% 39
2025
Q1 		$5.89K Sell
87
-393
-82% -$23.5K ﹤0.01% 1089
2024
Q4 		$21.6K Buy
480
+112
+30% +$6.28K ﹤0.01% 831
2024
Q3 		$20.3K Sell
368
-1,951
-84% -$114K ﹤0.01% 846
2024
Q2 		$137K Sell
2,319
-40,369
-95% -$2.53M 0.02% 438
2024
Q1 		$2.38M Buy
42,688
+10,807
+34% +$826K 0.36% 69
2023
Q4 		$2.52M Buy
31,881
+4,422
+16% +$315K 0.36% 61
2023
Q3 		$1.92M Buy
27,459
+7,035
+34% +$498K 0.31% 87
2023
Q2 		$1.41M Buy
20,424
+11,966
+141% +$851K 0.22% 124
2023
Q1 		$629K Sell
8,458
-172
-2% -$14.4K 0.11% 228
2022
Q4 		$804K Sell
8,630
-456
-5% -$44K 0.15% 171
2022
Q3 		$867K Sell
9,086
-382
-4% -$37.8K 0.15% 162
2022
Q2 		$877K Buy
9,468
+2,323
+33% +$227K 0.16% 159
2022
Q1 		$687K Buy
+7,145
New +$751K 0.13% 195

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Continuum Advisory's CVS Position: Q1 2026 in Review

Continuum Advisory increased its CVS Health (CVS) stake by 2.2% in Q1 2026, buying an estimated $136K and bringing the position to 80,736 shares worth $5.8M. The position accounts for 0.56% of the portfolio, ranked #40.

Continuum Advisory first reported a position in CVS in Q1 2022 and has held it in 17 quarters since. The position peaked at $6.27M in Q4 2025. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Continuum Advisory held 80,736 shares of CVS Health worth $5.8M as of Q1 2026.
  • Continuum Advisory bought 1,763 CVS Health shares in Q1 2026, an estimated $136K.
  • CVS Health made up 0.56% of Continuum Advisory's portfolio in Q1 2026, its #40 holding.
  • Continuum Advisory first reported a position in CVS Health in Q1 2022 and has held it in 17 quarters since.
  • Continuum Advisory's CVS Health position peaked at $6.27M in Q4 2025.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Continuum Advisory's 13F filing for Q1 2026, filed 22 Apr 2026.